Global Nuclear Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029
The global Nuclear Radiopharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report studies the global Nuclear Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Radiopharmaceutical total production and demand, 2018-2029, (Units)
Global Nuclear Radiopharmaceutical total production value, 2018-2029, (USD Million)
Global Nuclear Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Nuclear Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Nuclear Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)
This reports profiles key players in the global Nuclear Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and China Isotope & Radiation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Radiopharmaceutical Market, By Region:
1. How big is the global Nuclear Radiopharmaceutical market?
2. What is the demand of the global Nuclear Radiopharmaceutical market?
3. What is the year over year growth of the global Nuclear Radiopharmaceutical market?
4. What is the production and production value of the global Nuclear Radiopharmaceutical market?
5. Who are the key producers in the global Nuclear Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report studies the global Nuclear Radiopharmaceutical production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Radiopharmaceutical that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Radiopharmaceutical total production and demand, 2018-2029, (Units)
Global Nuclear Radiopharmaceutical total production value, 2018-2029, (USD Million)
Global Nuclear Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Nuclear Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share
Global Nuclear Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)
This reports profiles key players in the global Nuclear Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and China Isotope & Radiation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Radiopharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Radiopharmaceutical Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Diagnostic
- Therapeutic
- Oncology
- Thyroid
- Cardiology
- Others
- Nihon Medi-Physics Co.,Ltd.
- Curium Pharma
- Cardinal Health
- Bayer Global
- GE Healthcare
- Mallinckrodt Pharmaceuticals
- Bracco Group
- Advanced Molecular-imaging Solution
- China Isotope & Radiation
- Ciaeriar
- Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
1. How big is the global Nuclear Radiopharmaceutical market?
2. What is the demand of the global Nuclear Radiopharmaceutical market?
3. What is the year over year growth of the global Nuclear Radiopharmaceutical market?
4. What is the production and production value of the global Nuclear Radiopharmaceutical market?
5. Who are the key producers in the global Nuclear Radiopharmaceutical market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Radiopharmaceutical Introduction
1.2 World Nuclear Radiopharmaceutical Supply & Forecast
1.2.1 World Nuclear Radiopharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Radiopharmaceutical Production (2018-2029)
1.2.3 World Nuclear Radiopharmaceutical Pricing Trends (2018-2029)
1.3 World Nuclear Radiopharmaceutical Production by Region (Based on Production Site)
1.3.1 World Nuclear Radiopharmaceutical Production Value by Region (2018-2029)
1.3.2 World Nuclear Radiopharmaceutical Production by Region (2018-2029)
1.3.3 World Nuclear Radiopharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Nuclear Radiopharmaceutical Production (2018-2029)
1.3.5 Europe Nuclear Radiopharmaceutical Production (2018-2029)
1.3.6 China Nuclear Radiopharmaceutical Production (2018-2029)
1.3.7 Japan Nuclear Radiopharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Radiopharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Radiopharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Radiopharmaceutical Demand (2018-2029)
2.2 World Nuclear Radiopharmaceutical Consumption by Region
2.2.1 World Nuclear Radiopharmaceutical Consumption by Region (2018-2023)
2.2.2 World Nuclear Radiopharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Radiopharmaceutical Consumption (2018-2029)
2.4 China Nuclear Radiopharmaceutical Consumption (2018-2029)
2.5 Europe Nuclear Radiopharmaceutical Consumption (2018-2029)
2.6 Japan Nuclear Radiopharmaceutical Consumption (2018-2029)
2.7 South Korea Nuclear Radiopharmaceutical Consumption (2018-2029)
2.8 ASEAN Nuclear Radiopharmaceutical Consumption (2018-2029)
2.9 India Nuclear Radiopharmaceutical Consumption (2018-2029)
3 WORLD NUCLEAR RADIOPHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Radiopharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Radiopharmaceutical Production by Manufacturer (2018-2023)
3.3 World Nuclear Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Nuclear Radiopharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Radiopharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Radiopharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Radiopharmaceutical in 2022
3.6 Nuclear Radiopharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Nuclear Radiopharmaceutical Market: Region Footprint
3.6.2 Nuclear Radiopharmaceutical Market: Company Product Type Footprint
3.6.3 Nuclear Radiopharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Radiopharmaceutical Production Value Comparison
4.1.1 United States VS China: Nuclear Radiopharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Radiopharmaceutical Production Comparison
4.2.1 United States VS China: Nuclear Radiopharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Radiopharmaceutical Consumption Comparison
4.3.1 United States VS China: Nuclear Radiopharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
4.5 China Based Nuclear Radiopharmaceutical Manufacturers and Market Share
4.5.1 China Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
4.6 Rest of World Based Nuclear Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Radiopharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Diagnostic
5.2.2 Therapeutic
5.3 Market Segment by Type
5.3.1 World Nuclear Radiopharmaceutical Production by Type (2018-2029)
5.3.2 World Nuclear Radiopharmaceutical Production Value by Type (2018-2029)
5.3.3 World Nuclear Radiopharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Radiopharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Radiopharmaceutical Production by Application (2018-2029)
6.3.2 World Nuclear Radiopharmaceutical Production Value by Application (2018-2029)
6.3.3 World Nuclear Radiopharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Details
7.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
7.1.6 Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
7.2 Curium Pharma
7.2.1 Curium Pharma Details
7.2.2 Curium Pharma Major Business
7.2.3 Curium Pharma Nuclear Radiopharmaceutical Product and Services
7.2.4 Curium Pharma Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Curium Pharma Recent Developments/Updates
7.2.6 Curium Pharma Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Nuclear Radiopharmaceutical Product and Services
7.3.4 Cardinal Health Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Bayer Global
7.4.1 Bayer Global Details
7.4.2 Bayer Global Major Business
7.4.3 Bayer Global Nuclear Radiopharmaceutical Product and Services
7.4.4 Bayer Global Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Global Recent Developments/Updates
7.4.6 Bayer Global Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Nuclear Radiopharmaceutical Product and Services
7.5.4 GE Healthcare Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Details
7.6.2 Mallinckrodt Pharmaceuticals Major Business
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product and Services
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.6.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Bracco Group
7.7.1 Bracco Group Details
7.7.2 Bracco Group Major Business
7.7.3 Bracco Group Nuclear Radiopharmaceutical Product and Services
7.7.4 Bracco Group Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bracco Group Recent Developments/Updates
7.7.6 Bracco Group Competitive Strengths & Weaknesses
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Details
7.8.2 Advanced Molecular-imaging Solution Major Business
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product and Services
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
7.8.6 Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Product and Services
7.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Ciaeriar
7.10.1 Ciaeriar Details
7.10.2 Ciaeriar Major Business
7.10.3 Ciaeriar Nuclear Radiopharmaceutical Product and Services
7.10.4 Ciaeriar Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ciaeriar Recent Developments/Updates
7.10.6 Ciaeriar Competitive Strengths & Weaknesses
7.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
7.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
7.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
7.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Radiopharmaceutical Industry Chain
8.2 Nuclear Radiopharmaceutical Upstream Analysis
8.2.1 Nuclear Radiopharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Radiopharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Radiopharmaceutical Production Mode
8.6 Nuclear Radiopharmaceutical Procurement Model
8.7 Nuclear Radiopharmaceutical Industry Sales Model and Sales Channels
8.7.1 Nuclear Radiopharmaceutical Sales Model
8.7.2 Nuclear Radiopharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nuclear Radiopharmaceutical Introduction
1.2 World Nuclear Radiopharmaceutical Supply & Forecast
1.2.1 World Nuclear Radiopharmaceutical Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Radiopharmaceutical Production (2018-2029)
1.2.3 World Nuclear Radiopharmaceutical Pricing Trends (2018-2029)
1.3 World Nuclear Radiopharmaceutical Production by Region (Based on Production Site)
1.3.1 World Nuclear Radiopharmaceutical Production Value by Region (2018-2029)
1.3.2 World Nuclear Radiopharmaceutical Production by Region (2018-2029)
1.3.3 World Nuclear Radiopharmaceutical Average Price by Region (2018-2029)
1.3.4 North America Nuclear Radiopharmaceutical Production (2018-2029)
1.3.5 Europe Nuclear Radiopharmaceutical Production (2018-2029)
1.3.6 China Nuclear Radiopharmaceutical Production (2018-2029)
1.3.7 Japan Nuclear Radiopharmaceutical Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Radiopharmaceutical Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Radiopharmaceutical Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Radiopharmaceutical Demand (2018-2029)
2.2 World Nuclear Radiopharmaceutical Consumption by Region
2.2.1 World Nuclear Radiopharmaceutical Consumption by Region (2018-2023)
2.2.2 World Nuclear Radiopharmaceutical Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Radiopharmaceutical Consumption (2018-2029)
2.4 China Nuclear Radiopharmaceutical Consumption (2018-2029)
2.5 Europe Nuclear Radiopharmaceutical Consumption (2018-2029)
2.6 Japan Nuclear Radiopharmaceutical Consumption (2018-2029)
2.7 South Korea Nuclear Radiopharmaceutical Consumption (2018-2029)
2.8 ASEAN Nuclear Radiopharmaceutical Consumption (2018-2029)
2.9 India Nuclear Radiopharmaceutical Consumption (2018-2029)
3 WORLD NUCLEAR RADIOPHARMACEUTICAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nuclear Radiopharmaceutical Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Radiopharmaceutical Production by Manufacturer (2018-2023)
3.3 World Nuclear Radiopharmaceutical Average Price by Manufacturer (2018-2023)
3.4 Nuclear Radiopharmaceutical Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Radiopharmaceutical Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Radiopharmaceutical in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Radiopharmaceutical in 2022
3.6 Nuclear Radiopharmaceutical Market: Overall Company Footprint Analysis
3.6.1 Nuclear Radiopharmaceutical Market: Region Footprint
3.6.2 Nuclear Radiopharmaceutical Market: Company Product Type Footprint
3.6.3 Nuclear Radiopharmaceutical Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Radiopharmaceutical Production Value Comparison
4.1.1 United States VS China: Nuclear Radiopharmaceutical Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Radiopharmaceutical Production Comparison
4.2.1 United States VS China: Nuclear Radiopharmaceutical Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Radiopharmaceutical Consumption Comparison
4.3.1 United States VS China: Nuclear Radiopharmaceutical Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
4.5 China Based Nuclear Radiopharmaceutical Manufacturers and Market Share
4.5.1 China Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
4.6 Rest of World Based Nuclear Radiopharmaceutical Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Radiopharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Diagnostic
5.2.2 Therapeutic
5.3 Market Segment by Type
5.3.1 World Nuclear Radiopharmaceutical Production by Type (2018-2029)
5.3.2 World Nuclear Radiopharmaceutical Production Value by Type (2018-2029)
5.3.3 World Nuclear Radiopharmaceutical Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Radiopharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Radiopharmaceutical Production by Application (2018-2029)
6.3.2 World Nuclear Radiopharmaceutical Production Value by Application (2018-2029)
6.3.3 World Nuclear Radiopharmaceutical Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Details
7.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
7.1.6 Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
7.2 Curium Pharma
7.2.1 Curium Pharma Details
7.2.2 Curium Pharma Major Business
7.2.3 Curium Pharma Nuclear Radiopharmaceutical Product and Services
7.2.4 Curium Pharma Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Curium Pharma Recent Developments/Updates
7.2.6 Curium Pharma Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Nuclear Radiopharmaceutical Product and Services
7.3.4 Cardinal Health Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Bayer Global
7.4.1 Bayer Global Details
7.4.2 Bayer Global Major Business
7.4.3 Bayer Global Nuclear Radiopharmaceutical Product and Services
7.4.4 Bayer Global Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Global Recent Developments/Updates
7.4.6 Bayer Global Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Nuclear Radiopharmaceutical Product and Services
7.5.4 GE Healthcare Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Details
7.6.2 Mallinckrodt Pharmaceuticals Major Business
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product and Services
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.6.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Bracco Group
7.7.1 Bracco Group Details
7.7.2 Bracco Group Major Business
7.7.3 Bracco Group Nuclear Radiopharmaceutical Product and Services
7.7.4 Bracco Group Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bracco Group Recent Developments/Updates
7.7.6 Bracco Group Competitive Strengths & Weaknesses
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Details
7.8.2 Advanced Molecular-imaging Solution Major Business
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product and Services
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
7.8.6 Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Product and Services
7.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Ciaeriar
7.10.1 Ciaeriar Details
7.10.2 Ciaeriar Major Business
7.10.3 Ciaeriar Nuclear Radiopharmaceutical Product and Services
7.10.4 Ciaeriar Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ciaeriar Recent Developments/Updates
7.10.6 Ciaeriar Competitive Strengths & Weaknesses
7.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
7.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
7.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
7.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.11.6 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Radiopharmaceutical Industry Chain
8.2 Nuclear Radiopharmaceutical Upstream Analysis
8.2.1 Nuclear Radiopharmaceutical Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Radiopharmaceutical Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Radiopharmaceutical Production Mode
8.6 Nuclear Radiopharmaceutical Procurement Model
8.7 Nuclear Radiopharmaceutical Industry Sales Model and Sales Channels
8.7.1 Nuclear Radiopharmaceutical Sales Model
8.7.2 Nuclear Radiopharmaceutical Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Radiopharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Radiopharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Radiopharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Radiopharmaceutical Production by Region (2018-2023) & (Units)
Table 7. World Nuclear Radiopharmaceutical Production by Region (2024-2029) & (Units)
Table 8. World Nuclear Radiopharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Nuclear Radiopharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Nuclear Radiopharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Radiopharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Radiopharmaceutical Major Market Trends
Table 13. World Nuclear Radiopharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Nuclear Radiopharmaceutical Consumption by Region (2018-2023) & (Units)
Table 15. World Nuclear Radiopharmaceutical Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Nuclear Radiopharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Radiopharmaceutical Producers in 2022
Table 18. World Nuclear Radiopharmaceutical Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Nuclear Radiopharmaceutical Producers in 2022
Table 20. World Nuclear Radiopharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Nuclear Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Nuclear Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Nuclear Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Nuclear Radiopharmaceutical Competitive Factors
Table 27. Nuclear Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Nuclear Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Radiopharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Radiopharmaceutical Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Nuclear Radiopharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 37. China Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 47. World Nuclear Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Radiopharmaceutical Production by Type (2018-2023) & (Units)
Table 49. World Nuclear Radiopharmaceutical Production by Type (2024-2029) & (Units)
Table 50. World Nuclear Radiopharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Radiopharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Radiopharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Radiopharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Radiopharmaceutical Production by Application (2018-2023) & (Units)
Table 56. World Nuclear Radiopharmaceutical Production by Application (2024-2029) & (Units)
Table 57. World Nuclear Radiopharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Radiopharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Radiopharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Radiopharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Nihon Medi-Physics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Nihon Medi-Physics Co.,Ltd. Major Business
Table 63. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
Table 64. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
Table 66. Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
Table 67. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Curium Pharma Major Business
Table 69. Curium Pharma Nuclear Radiopharmaceutical Product and Services
Table 70. Curium Pharma Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Curium Pharma Recent Developments/Updates
Table 72. Curium Pharma Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Nuclear Radiopharmaceutical Product and Services
Table 76. Cardinal Health Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Global Major Business
Table 81. Bayer Global Nuclear Radiopharmaceutical Product and Services
Table 82. Bayer Global Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Global Recent Developments/Updates
Table 84. Bayer Global Competitive Strengths & Weaknesses
Table 85. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. GE Healthcare Major Business
Table 87. GE Healthcare Nuclear Radiopharmaceutical Product and Services
Table 88. GE Healthcare Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GE Healthcare Recent Developments/Updates
Table 90. GE Healthcare Competitive Strengths & Weaknesses
Table 91. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mallinckrodt Pharmaceuticals Major Business
Table 93. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product and Services
Table 94. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 96. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Bracco Group Basic Information, Manufacturing Base and Competitors
Table 98. Bracco Group Major Business
Table 99. Bracco Group Nuclear Radiopharmaceutical Product and Services
Table 100. Bracco Group Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bracco Group Recent Developments/Updates
Table 102. Bracco Group Competitive Strengths & Weaknesses
Table 103. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 104. Advanced Molecular-imaging Solution Major Business
Table 105. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product and Services
Table 106. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 108. Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Nuclear Radiopharmaceutical Product and Services
Table 112. China Isotope & Radiation Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 116. Ciaeriar Major Business
Table 117. Ciaeriar Nuclear Radiopharmaceutical Product and Services
Table 118. Ciaeriar Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ciaeriar Recent Developments/Updates
Table 120. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 121. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
Table 122. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
Table 123. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nuclear Radiopharmaceutical Upstream (Raw Materials)
Table 125. Nuclear Radiopharmaceutical Typical Customers
Table 126. Nuclear Radiopharmaceutical Typical Distributors
Table 1. World Nuclear Radiopharmaceutical Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Radiopharmaceutical Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Radiopharmaceutical Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Radiopharmaceutical Production by Region (2018-2023) & (Units)
Table 7. World Nuclear Radiopharmaceutical Production by Region (2024-2029) & (Units)
Table 8. World Nuclear Radiopharmaceutical Production Market Share by Region (2018-2023)
Table 9. World Nuclear Radiopharmaceutical Production Market Share by Region (2024-2029)
Table 10. World Nuclear Radiopharmaceutical Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Radiopharmaceutical Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Radiopharmaceutical Major Market Trends
Table 13. World Nuclear Radiopharmaceutical Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Nuclear Radiopharmaceutical Consumption by Region (2018-2023) & (Units)
Table 15. World Nuclear Radiopharmaceutical Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Nuclear Radiopharmaceutical Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Radiopharmaceutical Producers in 2022
Table 18. World Nuclear Radiopharmaceutical Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Nuclear Radiopharmaceutical Producers in 2022
Table 20. World Nuclear Radiopharmaceutical Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Radiopharmaceutical Company Evaluation Quadrant
Table 22. World Nuclear Radiopharmaceutical Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Radiopharmaceutical Production Site of Key Manufacturer
Table 24. Nuclear Radiopharmaceutical Market: Company Product Type Footprint
Table 25. Nuclear Radiopharmaceutical Market: Company Product Application Footprint
Table 26. Nuclear Radiopharmaceutical Competitive Factors
Table 27. Nuclear Radiopharmaceutical New Entrant and Capacity Expansion Plans
Table 28. Nuclear Radiopharmaceutical Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Radiopharmaceutical Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Radiopharmaceutical Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Nuclear Radiopharmaceutical Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 37. China Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Radiopharmaceutical Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Market Share (2018-2023)
Table 47. World Nuclear Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Radiopharmaceutical Production by Type (2018-2023) & (Units)
Table 49. World Nuclear Radiopharmaceutical Production by Type (2024-2029) & (Units)
Table 50. World Nuclear Radiopharmaceutical Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Radiopharmaceutical Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Radiopharmaceutical Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Radiopharmaceutical Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Radiopharmaceutical Production by Application (2018-2023) & (Units)
Table 56. World Nuclear Radiopharmaceutical Production by Application (2024-2029) & (Units)
Table 57. World Nuclear Radiopharmaceutical Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Radiopharmaceutical Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Radiopharmaceutical Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Radiopharmaceutical Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Nihon Medi-Physics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Nihon Medi-Physics Co.,Ltd. Major Business
Table 63. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
Table 64. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
Table 66. Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
Table 67. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Curium Pharma Major Business
Table 69. Curium Pharma Nuclear Radiopharmaceutical Product and Services
Table 70. Curium Pharma Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Curium Pharma Recent Developments/Updates
Table 72. Curium Pharma Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Nuclear Radiopharmaceutical Product and Services
Table 76. Cardinal Health Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Global Major Business
Table 81. Bayer Global Nuclear Radiopharmaceutical Product and Services
Table 82. Bayer Global Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Global Recent Developments/Updates
Table 84. Bayer Global Competitive Strengths & Weaknesses
Table 85. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. GE Healthcare Major Business
Table 87. GE Healthcare Nuclear Radiopharmaceutical Product and Services
Table 88. GE Healthcare Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GE Healthcare Recent Developments/Updates
Table 90. GE Healthcare Competitive Strengths & Weaknesses
Table 91. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mallinckrodt Pharmaceuticals Major Business
Table 93. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product and Services
Table 94. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 96. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Bracco Group Basic Information, Manufacturing Base and Competitors
Table 98. Bracco Group Major Business
Table 99. Bracco Group Nuclear Radiopharmaceutical Product and Services
Table 100. Bracco Group Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bracco Group Recent Developments/Updates
Table 102. Bracco Group Competitive Strengths & Weaknesses
Table 103. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 104. Advanced Molecular-imaging Solution Major Business
Table 105. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product and Services
Table 106. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 108. Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Nuclear Radiopharmaceutical Product and Services
Table 112. China Isotope & Radiation Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 116. Ciaeriar Major Business
Table 117. Ciaeriar Nuclear Radiopharmaceutical Product and Services
Table 118. Ciaeriar Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ciaeriar Recent Developments/Updates
Table 120. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 121. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
Table 122. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product and Services
Table 123. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Nuclear Radiopharmaceutical Upstream (Raw Materials)
Table 125. Nuclear Radiopharmaceutical Typical Customers
Table 126. Nuclear Radiopharmaceutical Typical Distributors
LIST OF FIGURES
Figure 1. Nuclear Radiopharmaceutical Picture
Figure 2. World Nuclear Radiopharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Radiopharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 5. World Nuclear Radiopharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Radiopharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 9. Europe Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 10. China Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 11. Japan Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 12. Nuclear Radiopharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 15. World Nuclear Radiopharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 17. China Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 18. Europe Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 19. Japan Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 20. South Korea Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 21. ASEAN Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 22. India Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Nuclear Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Radiopharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Radiopharmaceutical Markets in 2022
Figure 26. United States VS China: Nuclear Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 32. World Nuclear Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Radiopharmaceutical Production Value Market Share by Type in 2022
Figure 34. Diagnostic
Figure 35. Therapeutic
Figure 36. World Nuclear Radiopharmaceutical Production Market Share by Type (2018-2029)
Figure 37. World Nuclear Radiopharmaceutical Production Value Market Share by Type (2018-2029)
Figure 38. World Nuclear Radiopharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nuclear Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nuclear Radiopharmaceutical Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Thyroid
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Nuclear Radiopharmaceutical Production Market Share by Application (2018-2029)
Figure 46. World Nuclear Radiopharmaceutical Production Value Market Share by Application (2018-2029)
Figure 47. World Nuclear Radiopharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nuclear Radiopharmaceutical Industry Chain
Figure 49. Nuclear Radiopharmaceutical Procurement Model
Figure 50. Nuclear Radiopharmaceutical Sales Model
Figure 51. Nuclear Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Nuclear Radiopharmaceutical Picture
Figure 2. World Nuclear Radiopharmaceutical Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Radiopharmaceutical Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 5. World Nuclear Radiopharmaceutical Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Radiopharmaceutical Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Radiopharmaceutical Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 9. Europe Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 10. China Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 11. Japan Nuclear Radiopharmaceutical Production (2018-2029) & (Units)
Figure 12. Nuclear Radiopharmaceutical Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 15. World Nuclear Radiopharmaceutical Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 17. China Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 18. Europe Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 19. Japan Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 20. South Korea Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 21. ASEAN Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 22. India Nuclear Radiopharmaceutical Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Nuclear Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Radiopharmaceutical Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Radiopharmaceutical Markets in 2022
Figure 26. United States VS China: Nuclear Radiopharmaceutical Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Radiopharmaceutical Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Radiopharmaceutical Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Radiopharmaceutical Production Market Share 2022
Figure 32. World Nuclear Radiopharmaceutical Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Radiopharmaceutical Production Value Market Share by Type in 2022
Figure 34. Diagnostic
Figure 35. Therapeutic
Figure 36. World Nuclear Radiopharmaceutical Production Market Share by Type (2018-2029)
Figure 37. World Nuclear Radiopharmaceutical Production Value Market Share by Type (2018-2029)
Figure 38. World Nuclear Radiopharmaceutical Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nuclear Radiopharmaceutical Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nuclear Radiopharmaceutical Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Thyroid
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Nuclear Radiopharmaceutical Production Market Share by Application (2018-2029)
Figure 46. World Nuclear Radiopharmaceutical Production Value Market Share by Application (2018-2029)
Figure 47. World Nuclear Radiopharmaceutical Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nuclear Radiopharmaceutical Industry Chain
Figure 49. Nuclear Radiopharmaceutical Procurement Model
Figure 50. Nuclear Radiopharmaceutical Sales Model
Figure 51. Nuclear Radiopharmaceutical Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
